U.S. Capital Wealth Advisors LLC Purchases 7,279 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

U.S. Capital Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 63.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 18,749 shares of the healthcare conglomerate's stock after purchasing an additional 7,279 shares during the period. U.S. Capital Wealth Advisors LLC's holdings in UnitedHealth Group were worth $9,820,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Brighton Jones LLC grew its holdings in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its holdings in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Bank Pictet & Cie Europe AG grew its holdings in UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after acquiring an additional 9,872 shares during the last quarter. Proficio Capital Partners LLC grew its holdings in UnitedHealth Group by 52.1% in the 4th quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate's stock worth $1,889,000 after acquiring an additional 1,279 shares during the last quarter. Finally, Machina Capital S.A.S. bought a new stake in UnitedHealth Group in the 4th quarter worth $354,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $4.80 during trading hours on Monday, reaching $303.75. The company had a trading volume of 9,010,516 shares, compared to its average volume of 7,565,837. The business has a fifty day moving average price of $324.99 and a 200-day moving average price of $447.02. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm has a market cap of $275.54 billion, a PE ratio of 12.72, a price-to-earnings-growth ratio of 1.48 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.91%. UnitedHealth Group's payout ratio is presently 37.02%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO John F. Rex acquired 17,175 shares of the business's stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer directly owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock valued at $31,607,768 in the last three months. Corporate insiders own 0.28% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on UNH shares. TD Securities reaffirmed a "hold" rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. KeyCorp dropped their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Barclays dropped their target price on shares of UnitedHealth Group to $350.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Robert W. Baird cut shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target for the company. in a research report on Wednesday, June 11th. Finally, TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.